It achieves an 82% success rate in chronic plantar fasciitis that hasn't responded to conservative care 3 to 5 sessions over 3 to 5 weeks, with continued tissue remodeling happening for 8 to 12 weeks after the final treatment
There is one small pilot study in humans (examining knee pain, where 7 of 12 participants reported sustained improvement beyond 6 months) and a 2025 safety study confirming BPC-157 was well tolerated in healthy adults
1 Furthermore, the advent of PCSK9-inhibiting drugs in the mid-2010s paved the way for further LDL lowering and risk reduction in people whose cholesterol is not adequately controlled by statins, although cost remains a barrier
Diamond, T
You can adjust cover levels, add treatments, and see how different options affect your premium
Dosage and Administration Factors Aod 9604 peptide dosage represents the most significant factor influencing side effect profiles: Low-Dose Protocols (250-500 mcg): Associated with minimal side effects, primarily limited to mild injection site reactions
